7results about How to "Improve microcirculation disorder" patented technology

The invention discloses a pharmaceutical composition and application, and belongs to the technical field of traditional Chinese medicines. The invention discloses a pharmaceutical composition for treating dizziness. The pharmaceutical composition comprises the following raw materials: rhizoma pinellinae praeparata, rhizoma atractylodis macrocephalae fried with bran, gastrodia elata, uncaria, rhizoma cimicifugae, radix bupleuri, platycodon grandiflorum, ligusticum wallichii and radix cyathulae. The pharmaceutical composition takes rhizoma atractylodis macrocephalae stir-fried with bran as a monarch drug and has the effects of invigorating spleen and replenishing qi; rhizoma gastrodiae has the effects of calming liver wind and activating meridians to stop pain, and rhizoma pinellinae praeparata and rhizoma gastrodiae serve as ministerial drugs; the rhizoma chuanxiong has the effects of pungent temperature rising, qi promoting, blood activating, peripheral blood vessel expanding and microcirculation disturbance improving, the radix cyathulae has the effects of promoting blood circulation, removing blood stasis and descending sexual capacity, and the rhizoma chuanxiong and the radix cyathulae are mutually used and are increased and decreased, so that qi and blood circulatory flow is realized, and no blood stasis is caused; uncaria can clear heat, calm liver and clear head and eyes; in addition, a small amount of cimicifugae foetidae and radix bupleuri are used for lifting the clear yang to clear the head and eyes, and the five medicines are used as adjuvant drugs. The platycodon grandiflorum is used as the medicine and leads the medicine to move upwards to directly reach the head surface; the traditional Chinese medicine is used as a conductant drug. All the medicines are combined to lift clear yang, circulatory flow of qi and blood, both symptoms and root causes are taken into consideration, wind-phlegm is treated, and qi and blood are regulated together.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and discloses a TCM composition for treating cachexia and its preparation method. The composition comprises five grains (a type of insect), Astragalus membranaceus, stir-fried Atractylodes macrocephala, Polygonatum sibiricum, Lycium barbarum, Ophiopogon japonicus, Citrus reticulata peel, Panax notoginseng, and Glycyrrhiza uralensis. Stir-fried Atractylodes macrocephala can be replaced with Poria cocos, Ophiopogon japonicus can be replaced with Polygonatum odoratum, and Citrus reticulata peel can be replaced with Amomum villosum. This formula is based on the principle of "strengthening the body's resistance, detoxifying and removing blood stasis," enhancing the effects of invigorating the spleen and stomach, promoting body fluid production and moistening dryness, while avoiding greasy and cloying substances that may hinder digestion. The preparation method involves cleaning, pulverizing, decocting, extracting, and drying the raw materials to obtain granules. This composition can be used to treat cachexia caused by various tumors such as lung cancer and liver cancer. Animal experiments have verified that it can significantly increase patients' food intake, improve cancer-related fatigue, inhibit tumor growth, alleviate muscle atrophy and splenomegaly, regulate blood routine, and improve anemia and immune function, providing a safe and effective option for the treatment of cachexia.

The invention belongs to the field of medicines, and discloses application of notoginsenoside R1 (NgR1) in preparation of a medicine for treating chemotherapy-induced peripheral neuropathy. The NgR1 can significantly increase the mechanical pain threshold of chemotherapy pain, reduce inflammatory cell infiltration in dorsal root ganglions and expression of inflammatory factors such as IL-6, TNF-alpha and IL-1beta, also can significantly improve microcirculation disturbance, reduce expression of CGRP and c-fos in spinal cords, reduce expression of Cleved caspase 3 (a marker of cell apoptosis) in the dorsal root ganglions, and significantly improve chemotherapy pain. Therefore, the chemotherapy-induced peripheral neuropathy is relieved in a multi-target manner. The NgR1 treats the CIPN through three ways of relieving inflammatory response, improving microcirculation disturbance and inhibiting neuronal apoptosis, the safe and effective treatment purpose is achieved, and a new strategy is provided for clinical treatment of the CIPN.

The invention relates to application of a traditional Chinese medicine composition in preparation of a medicine for treating nerve deafness. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 5-25 parts of ligusticum wallichii and 1.5-8 parts of gastrodia elata. The traditional Chinese medicine composition is simple in compatibility and simple and convenient in preparation method, and has an obvious effect on treating nerve deafness.

The invention discloses a traditional Chinese medicine composition for treating glaucoma and a preparation method thereof, and relates to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 5 to 15 parts of fructus lycii, 2 to 10 parts of flos chrysanthemi, 5 to 15 parts of radix rehmanniae recen, 2 to 10 parts of fructus corni, 5 to 15 parts of rhizoma dioscoreae, 5 to 15 parts of poria cocos, 2 to 10 parts of cortex moutan, 2 to 10 parts of salted rhizoma alismatis, 2 to 10 parts of lucid ganoderma, 2 to 10 parts of fried fructus broussonetiae and 2 to 10 parts of rhizoma acori graminei. The traditional Chinese medicine composition has the effects of nourishing kidney and liver, nourishing yin and promoting salivation, clearing liver and improving vision, and promoting qi circulation and inducing diuresis, and is used for treating blurred vision, eye swelling and pain and uncomfortable eyes caused by glaucoma.

The present invention relates to the field of medical device technology, and in particular to a venous heart assist device and an interventional treatment device using the same. The venous heart assist device includes: a balloon catheter, a first balloon, a second balloon and a third balloon; when in use, first control the inflation of the second balloon to expand it in the right atrium; then control the inflation of the first balloon and the third balloon to expand them in the superior vena cava and the inferior vena cava respectively; thereafter, control the deflation of the second balloon to form a negative pressure in the right atrium; then control the deflation of the first balloon and the third balloon. The present invention uses three balloons, and at the same time combines the coordination of corresponding control timings, which can effectively improve the function of the right atrium, improve the perfusion effect, help improve microcirculation disorders, speed up the microblood flow rate, improve ischemia and hypoxia, and provide good assistance to microcirculation, which is conducive to promotion and application.

The present invention relates to the field of medical technology, and in particular to a Chinese medicine composition for improving microcirculation disorders, and a preparation method and application thereof. The Chinese medicine composition for improving microcirculation disorders of the present invention comprises the following raw materials in parts by weight: 1-10 parts of Gastrodia elata, 1-5 parts of Panax notoginseng, 1-10 parts of lotus seed heart, and 5-30 parts of corn silk. The formula is scientific and reasonable, the process is simple, the taste is good, the cost is low, it is safe and effective, it can improve microcirculation disorders, reduce vascular endothelial damage, and has a good therapeutic effect on diseases such as cardiovascular and cerebrovascular diseases. The Chinese medicine composition can be applied to the preparation of a medicine for treating microcirculation disorders, and its main component is the same source of medicine and food, with relatively few side effects, suitable for long-term use, and is particularly important for the management of chronic diseases.